US Broker Ratings

Illumina, Inc. (ILMN) Stock Analysis: Evaluating Growth Potential Amidst a Challenging Revenue Landscape

Illumina, Inc. (NASDAQ: ILMN) remains a pivotal player in the healthcare sector, specifically in diagnostics and research, despite facing some headwinds in its financial metrics. Notably,..

Thermo Fisher Scientific (TMO): Investor Outlook Reveals 6.27% Potential Upside Amid Strong Buy Ratings

Thermo Fisher Scientific Inc. (NYSE: TMO) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization..

The Cooper Companies, Inc. (COO) Stock Analysis: Insights into Its 12.91% Potential Upside

The Cooper Companies, Inc. (NYSE: COO) is a prominent player in the healthcare sector, specifically in the medical instruments and supplies industry. With a market capitalization..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Navigating Growth in Biotechnology with a 14% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, boasting a robust market capitalization of $108.04 billion. As a leader in..

GSK plc (GSK) Investor Outlook: Exploring Growth Potential Amidst a 3.81% Dividend Yield and Strong ROE

GSK plc (NYSE: GSK), a titan in the healthcare sector, continues to command investor attention with its robust market position in the drug manufacturing industry. Based..

Hologic, Inc. (HOLX): Analyst Consensus and Growth Potential in the Healthcare Sector

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, continues to evolve as a significant entity in the medical instruments and supplies industry. With..

ResMed Inc. (RMD) Stock Analysis: Uncovering a Potential 13.99% Upside in Healthcare Innovation

ResMed Inc. (RMD) is a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry. Headquartered in San Diego, California, ResMed is..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Navigating a $60.75 Billion Biotech Powerhouse

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, is capturing investors’ attention with its substantial market capitalization of $60.75 billion. Based in Cambridge,..

Sanofi (SNY) Stock Analysis: A 17% Upside Potential with Strong Dividend Yield

Sanofi (NASDAQ: SNY), a titan in the healthcare sector, is headquartered in Paris, France. With a market capitalization of $125.79 billion, Sanofi is a significant player..

Insulet Corporation (PODD) Stock Analysis: A 13% Potential Upside with Strong Buy Ratings

Insulet Corporation (NASDAQ: PODD) is making notable strides in the healthcare sector, specifically within the medical devices industry. Known for its innovative insulin delivery systems, Insulet..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A Healthcare Titan with Limited Upside Potential

IQVIA Holdings, Inc. (NYSE: IQV), a leader in the healthcare sector, is a noteworthy player in the diagnostics and research industry. With a market capitalization of..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a Potential 65% Upside in the Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT) is capturing the attention of investors in the biotechnology sector with its promising drug development pipeline and impressive market cap of..

Quest Diagnostics (DGX) Investor Outlook: Analyzing Potential Upside Amidst Robust Revenue Growth

For investors navigating the healthcare sector, Quest Diagnostics Incorporated (NYSE: DGX) presents an intriguing opportunity, bolstered by its substantial market capitalization of $20.27 billion. With its..

Veeva Systems Inc. (VEEV) Stock Analysis: A Strong Buy with 9.42% Potential Upside

Veeva Systems Inc. (NYSE: VEEV) is a prominent player in the healthcare sector, specifically within the health information services industry. As a leading provider of cloud-based..

The Cigna Group (CI) Stock Analysis: Exploring a 21.45% Upside Potential in the Healthcare Sector

The Cigna Group (NYSE: CI) has emerged as a compelling option for investors seeking a robust presence in the healthcare sector. With a market capitalization of..

Waters Corporation (WAT) Stock Analysis: Navigating a Healthcare Giant with Strong Revenue Growth and Robust Analyst Support

Waters Corporation (NYSE: WAT), a leader in the diagnostics and research industry within the healthcare sector, presents a compelling investment narrative with its robust revenue growth..

Stryker Corporation (SYK) Stock Analysis: 12.46% Potential Upside in the Medical Device Sector

Stryker Corporation (NYSE: SYK), a titan in the healthcare sector, stands at the forefront of the medical device industry. With a market capitalization of $145.96 billion,..

Agilent Technologies, Inc. (A) Stock Analysis: Navigating Growth with a 19.88% Return on Equity

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector specifically within diagnostics and research, continues to draw investor attention with its robust performance..

Bristol-Myers Squibb (BMY) Stock Analysis: A 21% Potential Upside in Healthcare Investment

Bristol-Myers Squibb Company (NYSE: BMY), a titan in the healthcare sector, offers intriguing opportunities for investors with its current market position and potential upside. With a..

Intuitive Surgical, Inc. (ISRG): Investor Outlook with an 8.74% Upside Potential

Intuitive Surgical, Inc. (NASDAQ: ISRG) continues to capture investor attention with its innovative contributions to the healthcare sector, specifically within the medical instruments and supplies industry...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds